Medical device manufacturers regularly groan about the cost and burden of regulatory compliance. With regulations changing every day around the world, paper-based or disjointed information systems cannot keep up. That is what most companies have, and they will struggle to comply without a hit to profits.
However, this need not be the reality. Companies can, rather than simply viewing traceability requirements as a necessary evil, re-frame traceability to find the opportunities it offers the business.
In fact, medical device companies can and must re-frame to survive. Given that some have seen the opportunity in end-to-end data flows and are thriving, you might think it’s obvious.
Poll: Should the UK’s railways be renationalised?
If only the track is nationalised then it is an emasculated one with limited function and improvements will be focused on existing commuter and large...